Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:RAIN

Rain Oncology (RAIN) Stock Price, News & Analysis

Rain Oncology logo

About Rain Oncology Stock (NASDAQ:RAIN)

Advanced Chart

Key Stats

Today's Range
$4.23
$5.14
50-Day Range
$1.20
$1.24
52-Week Range
$0.82
$11.32
Volume
9,104 shs
Average Volume
550,818 shs
Market Capitalization
$157.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

As of January 26, 2024, operates as a subsidiary of Pathos AI, Inc.

Receive RAIN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rain Oncology and its competitors with MarketBeat's FREE daily newsletter.

RAIN Stock News Headlines

Looking for ways to bring in extra cash?
These days folks are constantly looking for ways to bring in extra cash… Picking up extra hours, working weekends, and even getting second or third jobs! But what if there was a way to have a “side hustle” that doesn't require you picking up extra shifts or sacrificing your weekends? That my friends, is the beauty of the Weekend Side Hustle!
Recap: Wisconsin voters go to the polls for 2024 election
See More Headlines

RAIN Stock Analysis - Frequently Asked Questions

Rain Oncology Inc. (NASDAQ:RAIN) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.64) by $0.06.

Rain Oncology (RAIN) raised $126 million in an IPO on Friday, April 23rd 2021. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Citigroup, Piper Sandler and Guggenheim Securities served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rain Oncology investors own include CRISPR Therapeutics (CRSP), Meta Platforms (META), UiPath (PATH), Recursion Pharmaceuticals (RXRX), Alibaba Group (BABA), NVIDIA (NVDA) and

Company Calendar

Last Earnings
11/10/2021
Today
1/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RAIN
Fax
N/A
Employees
63
Year Founded
N/A

Profitability

Net Income
$-75,720,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$3.11 per share

Miscellaneous

Free Float
30,047,000
Market Cap
$157.53 million
Optionable
No Data
Beta
0.27
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:RAIN) was last updated on 1/15/2025 by MarketBeat.com Staff
From Our Partners